Breast cancer drug Herceptin 'prolongs life'

Researchers from the Royal Marsden Hospital in London have confirmed that giving Herceptin to women with certain types of breast cancer does prolong their lives. The study, published in The Lancet, followed women for two years after treatment and found a 2.7 per cent ...

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here